Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$135,433,574
+$7,699,158 QoQ
Shares Held
1,071,977
+17.0% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#112
of 2,266 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,791,248,361 across 11 Drug Manufacturers - General names. GILD ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
726,199 | $871,024,939 | |
| 2 | JNJ |
Johnson & Johnson
|
2,566,595 | $651,838,132 | |
| 3 | ABBV |
AbbVie Inc.
|
1,598,568 | $402,263,651 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,030,023 | $260,857,955 | |
| 5 | AMGN |
Amgen Inc
|
471,833 | $170,860,165 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
1,071,977 | $135,433,574 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,716,000 | $98,875,920 | |
| 8 | PFE |
Pfizer Inc
|
3,801,302 | $91,535,352 |
All Filings in GILD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,433,574 | 1,071,977 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $127,734,416 | 916,513 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $103,244,592 | 841,165 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $150,432,528 | 1,355,248 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $161,119,831 | 1,453,232 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $147,923,031 | 1,320,152 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $158,334,188 | 1,714,130 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $7,426,597 | 101,387 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $96,074,537 | 1,246,588 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $135,422,306 | 1,632,184 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $133,641,321 | 1,556,684 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $59,899,571 | 970,977 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $67,390,021 | 1,090,277 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,413,032 | 191,977 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $73,392,517 | 1,010,777 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,455,968 | 49,477 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $42,608,984 | 618,777 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,044,351 | 62,577 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,727,300 | 63,977 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $18,639,596 | 294,977 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $83,157,417 | 1,112,325 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||